Chintalapudi Nainisha, Fram Brianna R, Odum Susan, Seymour Rachel B, Karunakar Madhav A, Hsu Joseph R, Kempton Laurence, Phelps Kevin, Sims Stephen, Medda Suman, Sweeney Juliette, Hickson Kate, Young Catherine, Kamath Priyanka
Department of Orthopaedic Surgery, Atrium Health Musculoskeletal Institute, Charlotte, NC.
OTA Int. 2024 Oct 1;7(4):e345. doi: 10.1097/OI9.0000000000000345. eCollection 2024 Dec.
To identify risk factors for developing a fracture-related infection in operatively treated ballistic tibia fractures and to report the microbiologic results of intraoperative cultures.
Retrospective review.
Level 1 trauma center.
PATIENTS/PARTICIPANTS: One hundred thirty-three adults with operatively treated low-velocity ballistic tibia fractures, from 2011 to 2021.
One dose of prophylactic cefazolin or equivalent as well as perioperative prophylaxis.
Deep infection rate.
The deep infection rate was 12% (16/134) with no significant difference in injury characteristics, index surgical characteristics, or time to antibiotics between the groups ( > 0.05). Patients who were slightly older (35.5 vs. 27 median years, = 0.005) and with higher median body mass indexes (BMIs) (30.09 vs. 24.51, = 0.021) developed a deep infection. 56.3% of patients presented with signs of infection within the first 100 days after injury. Nine patients had polymicrobial infections. There were 29 isolated organisms, 69% were uncovered by first-generation cephalosporin prophylaxis (anaerobes, gram-negative rods, ), and 50% of patients developed recalcitrant infection and required a second reoperation where 6 organisms were isolated, half of which were not covered by first-generation prophylaxis ().
We found a deep infection rate of 12% among ballistic tibia fractures receiving standard-of-care antibiotic prophylaxis. Increased age and body mass index were associated with deep infections. Half became recalcitrant requiring a second reoperation. 66.7% of isolated organisms were not covered by first-generation cephalosporin prophylaxis. Consideration should be given to treatment options such as broader prophylaxis or local antibiotic treatment.
IV.
确定手术治疗的弹道性胫骨骨折发生骨折相关感染的危险因素,并报告术中培养的微生物学结果。
回顾性研究。
一级创伤中心。
患者/参与者:2011年至2021年期间133例接受手术治疗的成人低速弹道性胫骨骨折患者。
一剂预防性头孢唑林或等效药物以及围手术期预防。
深部感染率。
深部感染率为12%(16/134),两组间损伤特征、初次手术特征或抗生素使用时间无显著差异(P>0.05)。年龄稍大(中位年龄35.5岁对27岁,P=0.005)和体重指数中位数较高(30.09对24.51,P=0.021)的患者发生深部感染。56.3%的患者在受伤后100天内出现感染迹象。9例患者发生混合感染。共分离出29种微生物,69%可被第一代头孢菌素预防(厌氧菌、革兰氏阴性杆菌)覆盖,50%的患者发生顽固性感染,需要二次手术,二次手术分离出6种微生物,其中一半未被第一代预防药物覆盖()。
我们发现在接受标准护理抗生素预防的弹道性胫骨骨折患者中,深部感染率为12%。年龄和体重指数增加与深部感染有关。一半患者感染顽固,需要二次手术。66.7%的分离微生物未被第一代头孢菌素预防覆盖。应考虑更广泛的预防或局部抗生素治疗等治疗方案。
四级。